ICM
ALGN icon

Invenomic Capital Management’s Align Technology ALGN Stock Holding History

Invenomic Capital Management’s Portfolio ALGN Stock Details ALGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,610
Closed -$7.28M – 152
2025
Q4 		$7.28M Buy
46,610
+6,254
+15% +$896K 0.34% 90
2025
Q3 		$5.05M Buy
40,356
+8,169
+25% +$1.28M 0.24% 100
2025
Q2 		$6.09M Buy
32,187
+9,681
+43% +$1.71M 0.35% 89
2025
Q1 		$3.58M Buy
+22,506
New +$4.42M 0.18% 130

Other funds holding ALGN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Invenomic Capital Management's ALGN Position: Q1 2026 in Review

Invenomic Capital Management sold out of Align Technology (ALGN) in Q1 2026, closing a stake of 46,610 shares — an estimated $7.28M sold.

Invenomic Capital Management first reported a position in ALGN in Q1 2025 and held it in 4 quarters. The position peaked at $7.28M in Q4 2025. 693 funds tracked by Wall St. Rank hold ALGN as of Q1 2026.

  • Invenomic Capital Management reported no remaining Align Technology position as of Q1 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 46,610 Align Technology shares in Q1 2026, an estimated $7.28M.
  • Invenomic Capital Management first reported a position in Align Technology in Q1 2025 and held it in 4 quarters.
  • Invenomic Capital Management's Align Technology position peaked at $7.28M in Q4 2025.
  • 693 funds tracked by Wall St. Rank held Align Technology as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.